Form 4: VolitionRx COO's Tax Withholding on RSU Vesting

VolitionRx's Chief Operating Officer, Gaetan Michel, had 11,362 shares withheld by the company to cover tax obligations related to the vesting of 22,725 restricted stock units.

Summary

• Gaetan Michel, Chief Operating Officer of VolitionRx Ltd (VNRX), had 11,362 shares of common stock withheld by the company.
• This withholding occurred on September 28, 2025, at a price of $0.605 per share.
• The shares were withheld to satisfy tax obligations arising from the settlement of 22,725 restricted stock units (RSUs) granted to Mr. Michel.
• No shares were sold by Mr. Michel or VolitionRx in this transaction; it was a tax-related withholding.
• Following this transaction, Mr. Michel directly beneficially owns 369,079 shares of VolitionRx common stock.

Sentiment

Score: 5

Explanation: This is a routine, non-discretionary transaction related to executive compensation, neither inherently positive nor negative for the company's immediate operational or financial prospects.

Positives

• The transaction represents the vesting of restricted stock units, a form of equity compensation for the Chief Operating Officer.
• No shares were sold by the reporting person, indicating continued holding of vested equity.

Negatives

• The reported disposition of shares is solely for tax withholding purposes and does not represent a discretionary sale by the insider.

Future Outlook

NA

Industry Context

NA

Related Party Transactions

• The transaction involves the company withholding shares from its Chief Operating Officer to cover tax obligations arising from the vesting of restricted stock units, a standard compensation practice.

Stakeholder Impact

• Shareholders: Indicates a routine compensation event for a key executive, with no direct market sale of shares by the insider.

Key Dates

Recommendation

This Form 4 reports a routine tax withholding event related to the vesting of restricted stock units for the Chief Operating Officer. It does not indicate any discretionary buying or selling by the insider that would suggest a change in the company's fundamental outlook or warrant a revised investment recommendation. Therefore, a 'hold' recommendation is appropriate as this filing provides no new material information to alter an existing investment thesis.

Keywords

VolitionRx, VNRX, Gaetan Michel, COO, Form 4, insider transaction, RSU, restricted stock units, tax withholding, beneficial ownership